Company | Gartner, Inc. |
Ticker | NYSE: IT |
Upcoming Earnings Date | August 4, 2026 (Pre-Market, 8:00 AM ET) |
Reporting Period | Q2 2026 (Quarter ended June 30, 2026) |
Preparation Date | August 3, 2026 |
Sector ETF Used | IGV (iShares Expanded Tech-Software Sector ETF) — used as IT services/software sector proxy |
Key Takeaway: The setup into Q2 2026 is cautiously constructive — consensus is a manageable bar, the federal headwind begins to lap, and Q2 is seasonally Gartner’s largest new-business quarter; the biggest swing factor is whether contract value (CV) acceleration materializes as management guided, or whether macro/geopolitical drag extends the timeline.
Bar: Consensus sits at $3.73 in operating EPS and $1.65B in revenue for Q2 2026 — a bar that reflects modest sequential improvement from Q1’s $3.32 beat and is broadly consistent with management’s raised full-year guidance issued May 5. The bar does not appear stretched; Gartner has beaten operating EPS in each of the last eight quarters, often by a wide margin, suggesting the street has not fully closed the gap to management’s typical outperformance cadence.
Guidance/Tone: Management raised full-year 2026 EBITDA guidance by $30M to ≥1.545B and operating EPS to ≥$13.25 at Q1 earnings (May 5), and explicitly guided Q2 EBITDA at or above $425M. At the June 4 Baird conference, CFO Craig Safian reaffirmed CV acceleration expectations, noted that many March-delayed deals closed in April, characterized Q2 as “a good bookings quarter,” and confirmed the Iran-war-related disruption “feels a little bit less risky” than in late March. Tone is cautiously optimistic with no incremental guidance cuts.
Estimate Trajectory: Operating EPS estimates for Q2 2026 have been essentially flat since the Q1 print, moving from $3.72 to $3.73 — a negligible revision that suggests the street is waiting for the print rather than pre-positioning. Revenue estimates have drifted slightly lower (~$1.655B post-Q1 to ~$1.647B currently), reflecting modest FX headwinds and consulting de-risking, but the gap to guidance is thin. The lack of upward revision despite management’s constructive tone represents potential cushion.
Stock Setup: IT has declined approximately 15% since the Q1 earnings date (May 5 close: $149.49; July 31 close: $151.02, but the stock hit a trough near $125 in late June before recovering). The stock trades at ~7.9x NTM EV/EBITDA versus ~10x six months ago — a 21% multiple compression over six months that has more than offset any estimate changes. At current levels, the stock appears to price in continued CV stagnation rather than the acceleration management is guiding toward, creating asymmetric upside if Q2 CV inflects.
Wildcard: The single biggest swing factor is the ex-federal CV growth rate — management guided ex-Fed CV to accelerate throughout 2026 (Q1 ex-Fed CV grew 3.5% YoY). A print above ~4–5% ex-Fed CV growth, combined with evidence that Q2 new business recovered from the March slowdown, could catalyze a meaningful re-rating. Conversely, any sign that the Iran-war disruption extended into Q2 or that consulting bookings disappointed would pressure the stock further.
Key Takeaway: Consensus is a manageable bar on both revenue and EPS, with the street essentially flat since the Q1 print. Contract Value is the primary swing factor — any acceleration above the Q1 1.0% YoY pace (or ex-Fed 3.5%) will be the key read for the stock on results day.
KPI | Q1 2026 Actual (Last Quarter) | Q2 2025 Actual (Prior Year Period) | Q2 2026 Consensus Estimate | YoY Change (Est. vs. PY) | Guidance (Q2 / FY) | Consensus vs. Guidance (% delta) |
Total Revenue ($M) | $1,511M | $1,687M | $1,647M | -2.4% | FY ≥$6,405M | FY cons. $6,426M; +0.3% above FY floor |
Operating EPS (Diluted) | $3.32 | $3.53 | $3.73 | +5.7% | FY ≥$13.25 | FY cons. $13.67; +3.2% above FY floor |
Total Contract Value ($B) | $5.268B | $5.196B | $5.291B | +1.8% | No explicit Q2 CV guidance; FY exit ~$5.5B implied | N/A (no explicit Q2 CV guidance) |
EBITDA - Operating ($M) | $400M (Adj. EBITDA ex-divested: $395M) | $443M | $429M | -3.2% | Q2 ≥$425M; FY ≥$1,545M | Q2 cons. $429M; +0.9% above Q2 floor |
Insights Revenue ($M) | $1,294M | $1,264M | $1,288M | +1.9% | FY ≥$5,198M (implied from FY rev. guidance) | N/A (no explicit Q2 Insights guidance) |
Consulting Revenue ($M) | $119M | $156M | $139M | -11.2% | FY ≥$511M (de-risked at Q1 earnings) | FY cons. $511M; ~flat to floor |
Free Cash Flow ($M) | $371M | $347M | $258M | -25.6% | FY ≥$1,160M | FY cons. $1,162M; +0.2% above FY floor |
Sources: Visible Alpha Consensus and Actuals Data (Total Revenue, Operating EPS, Total Contract Value, EBITDA - Operating, Insights Revenue, Consulting Revenue, Free Cash Flow); Q1 2026 Earnings Release and Transcript (May 5, 2026) for guidance figures.
Quarter | KPI | Reported | Consensus | Surprise % | Result |
Q1 2026 | Operating EPS | $3.32 | $2.89 | +14.9% | BEAT |
Q1 2026 | Total CV ($B) | $5.268B | $5.152B | +2.2% | BEAT |
Q4 2025 | Operating EPS | $3.94 | $3.50 | +12.6% | BEAT |
Q4 2025 | Total CV ($B) | $5.324B | $5.210B | +2.2% | BEAT |
Q3 2025 | Operating EPS | $2.76 | $2.45 | +12.7% | BEAT |
Q3 2025 | Total CV ($B) | $5.211B | $5.091B | +2.4% | BEAT |
Q2 2025 | Operating EPS | $3.53 | $3.32 | +6.3% | BEAT |
Q2 2025 | Total CV ($B) | $5.196B | $5.108B | +1.7% | BEAT |
Q1 2025 | Operating EPS | $2.98 | $2.73 | +9.2% | BEAT |
Q1 2025 | Total CV ($B) | $5.214B | $5.140B | +1.4% | BEAT |
Q4 2024 | Operating EPS | $5.45 | $3.25 | +67.7% | BEAT (large; includes one-time items) |
Q4 2024 | Total CV ($B) | $5.278B | $5.249B | +0.6% | BEAT |
Q3 2024 | Operating EPS | $2.50 | $2.38 | +5.0% | BEAT |
Q3 2024 | Total CV ($B) | $5.056B | $5.050B | +0.1% | BEAT |
Pattern: Gartner has beaten operating EPS consensus in each of the last eight quarters, with a median surprise of approximately +10%. Contract Value has also beaten consensus in each of the last eight quarters, though by a narrower margin (~1–2%). The consistent EPS beat pattern reflects management’s conservative guidance approach and aggressive buyback execution; the CV beat pattern is more modest and is the metric the market watches most closely for evidence of re-acceleration.
Source: Visible Alpha Consensus and Actuals Data.
Key Takeaway: Management raised full-year EBITDA, EPS, and FCF guidance at Q1 earnings (May 5) and has not revised guidance since. The June 4 Baird conference added constructive color on Q2 consulting bookings and CV acceleration, but introduced no numerical changes. Tone is cautiously optimistic with the federal headwind beginning to lap.
Metric | Initial Guidance (May 5, 2026 — Q1 Earnings Call) | Revised Guidance (Post-Earnings) | Current Consensus | Note |
Q2 2026 EBITDA | ≥$425M | — (no change) | $429M | Consensus sits +0.9% above the floor; no post-earnings revision to Q2 EBITDA guidance |
FY 2026 Consolidated Revenue | ≥$6,405M (FX-neutral growth of ~1%) | — (no change) | $6,426M | Raised from prior guidance at Q1 earnings to reflect FX tailwind; operationally unchanged. Consensus +0.3% above floor. |
FY 2026 EBITDA | ≥$1,545M (margin ≥24.1%) | — (no change) | $1,576M | ↑ Raised $30M at Q1 earnings (May 5); margin rebaselined to 24.1% floor. Consensus +2.0% above floor. |
FY 2026 Operating EPS | ≥$13.25 | — (no change) | $13.67 | ↑ Raised at Q1 earnings (May 5); reflects higher EBITDA and lower share count from $535M Q1 buyback. Consensus +3.2% above floor. |
FY 2026 Free Cash Flow | ≥$1,160M (137% GAAP net income conversion) | — (no change) | $1,162M | ↑ Raised at Q1 earnings (May 5). Consensus essentially at the floor. |
FY 2026 Diluted Shares (guidance basis) | 69M fully diluted weighted average shares | — (no change) | N/A | Incorporates Q1 repurchases only; additional buybacks in Q2 represent upside to EPS guidance |
CV Trajectory (qualitative) | Expects CV to accelerate throughout 2026; federal CV modeled flat; ex-Fed CV to accelerate | June 4 (Baird): Reaffirmed; noted Q2 is “a good bookings quarter”; March-delayed deals largely closed in April; Iran-war disruption “feels less risky” | N/A | Constructive tone maintained; no numerical change but qualitative improvement in confidence |
Consulting Revenue (FY 2026) | De-risked at Q1 earnings; guidance reduced to reflect deferred Q1 bookings and contract optimization volatility | June 4 (Baird): Q2 bookings expected to recover; contract optimization “extremely volatile” and “100% reliant on client decisions” | $511M | ↓ Lowered at Q1 earnings (May 5); management de-risked the line; consensus near the floor |
Sources: Q1 2026 Earnings Call Transcript and Earnings Release (May 5, 2026); Baird Global Consumer, Tech & Services Conference Transcript (June 4, 2026); Visible Alpha Consensus Data.
Key Takeaway: Estimates have been remarkably stable since the Q1 print — operating EPS for Q2 moved only +$0.01 and revenue drifted slightly lower. The lack of upward revision despite management’s constructive tone and raised full-year guidance suggests the street is skeptical of near-term CV acceleration, creating potential cushion if Q2 delivers.
KPI (Period) | Estimate ~5 Days Post Q1 Earnings (May 12, 2026) | Current Consensus (Aug 3, 2026) | Estimate Δ (%) | Initial Guidance (May 5 Q1 Call) | Current Guidance | Guidance Δ | Consensus vs. Guidance (%) |
Operating EPS — Q2 2026 | $3.72 | $3.73 | +0.3% | No explicit Q2 EPS guidance | No explicit Q2 EPS guidance | N/A | N/A |
Operating EPS — FY 2026 | $13.65 | $13.67 | +0.1% | ≥$13.25 | ≥$13.25 (unchanged) | No change | +3.2% above floor |
Total Revenue — Q2 2026 | $1,655M | $1,647M | -0.5% | No explicit Q2 revenue guidance | No explicit Q2 revenue guidance | N/A | N/A |
Total Revenue — FY 2026 | $6,447M | $6,426M | -0.3% | ≥$6,405M | ≥$6,405M (unchanged) | No change | +0.3% above floor |
Total Contract Value — Q2 2026 | $5.301B | $5.291B | -0.2% | No explicit Q2 CV guidance | No explicit Q2 CV guidance | N/A | N/A |
Total Contract Value — FY 2026 | $5.522B | $5.507B | -0.3% | No explicit FY CV guidance (qualitative: expects acceleration) | No explicit FY CV guidance | N/A | N/A |
EBITDA — Q2 2026 | $429M | $429M | Flat | ≥$425M | ≥$425M (unchanged) | No change | +0.9% above floor |
EBITDA — FY 2026 | $1,577M | $1,576M | -0.1% | ≥$1,545M | ≥$1,545M (unchanged) | No change | +2.0% above floor |
Commentary: Estimates are tracking guidance closely and have been essentially frozen since the Q1 print — a sign the street is in “wait and see” mode rather than pre-positioning for acceleration. The slight downward drift in revenue and CV estimates (both -0.2% to -0.5%) likely reflects modest FX headwinds and consulting de-risking, not a fundamental change in the demand outlook. The gap between consensus and guidance floors is thin on revenue and FCF but more meaningful on EBITDA (+2.0%) and EPS (+3.2%), consistent with Gartner’s historical pattern of conservative guidance.
Source: Visible Alpha Consensus and Actuals Data (revision history table, weekly frequency, May 8 – August 3, 2026); Q1 2026 Earnings Call Transcript (May 5, 2026) for guidance figures.
Key Takeaway: IT has dramatically underperformed both IGV and the S&P 500 since Q1 earnings, driven almost entirely by multiple compression (EV/EBITDA fell from ~10x to ~7.9x over six months) rather than estimate cuts. The stock’s recovery from the late-June trough (~$125) to ~$151 suggests some stabilization, but the stock remains well below pre-Q1 levels, pricing in continued CV stagnation.
IT vs. IGV vs. S&P 500 — Indexed to 100 at Q1 2026 Earnings Date (May 5, 2026). Source: Yahoo Finance / Stock Price Data.
Performance Summary (May 5 – July 31, 2026):
Series | May 5 Close | July 31 Close | Return | Trough (approx.) |
IT (Gartner) | $149.49 | $151.02 | +1.0% | ~$125 (late June) |
IGV (Software ETF) | $88.27 | $94.58 | +7.1% | ~$84 (late June) |
S&P 500 (SPY) | $723.77 | $747.03 | +3.2% | ~$725 (early June) |
Key Events Since Q1 Earnings:
Performance Decomposition: Over the past 12 months, IT has declined ~55%, with EV/EBITDA multiple contracting from ~16.3x to ~7.9x (a -51% multiple compression) accounting for the vast majority of the decline. Over the past 3 months, the stock is essentially flat (+3.5%) with the multiple also roughly flat (-0.6%), suggesting the de-rating has largely run its course. The 1-month recovery (+11.2%) has been driven by multiple expansion (+10.9%) rather than estimate revisions, consistent with a sentiment-driven bounce from oversold levels.
Source: Yahoo Finance / Stock Price Data; Stock Performance Decomposition Data.
Key Takeaway: Peer commentary from the last 60 days is broadly constructive for Gartner’s Q2 print. IBM, ExlService, Cognizant, and Accenture all reported in the last 60 days and collectively paint a picture of strong AI-driven demand for advisory and consulting services, clients moving from pilots to production, and enterprise IT budgets that are resilient on OpEx (favorable for Gartner subscriptions) even as CapEx-sensitive deals face timing delays. The primary negative read-through is Cognizant’s cautious tone on discretionary spending and Accenture’s geopolitical disruption commentary, which could signal continued pressure on Gartner’s new-business velocity.
Note on Scope: Only forward-looking commentary about the current reporting period (Q2 2026 / calendar Q2 2026) or commentary made after each peer’s last earnings call is included below. Prior-quarter results commentary is excluded.
IBM reported Q2 2026 results on July 22, 2026, providing the most recent and directly relevant peer read-through for Gartner’s Q2 print.
Positive Read-Throughs for Gartner:
Negative/Mixed Read-Throughs for Gartner:
ExlService reported Q2 2026 results on July 28–29, 2026, providing the most recent data point on enterprise AI services demand.
Positive Read-Throughs for Gartner:
Negative/Mixed Read-Throughs for Gartner:
Cognizant reported Q2 2026 results on July 29, 2026, providing the most cautious peer read-through of the group.
Positive Read-Throughs for Gartner:
Negative/Mixed Read-Throughs for Gartner:
Accenture reported Q3 FY2026 results on June 18, 2026 (covering the March–May 2026 period), providing commentary on the demand environment heading into Gartner’s Q2 2026 reporting period.
Positive Read-Throughs for Gartner:
Negative/Mixed Read-Throughs for Gartner:
Peer | Report Date | Key Positive Read-Through for IT | Key Negative/Mixed Read-Through for IT | Net Signal |
IBM | July 22, 2026 | OpEx software demand resilient; AI adoption early-stage (needs research); consulting signings +6% | Large CapEx deal slippage in late June; dynamic spending environment | Mildly Positive |
ExlService (EXLS) | July 28–29, 2026 | AI revenue +30% YoY; faster client decision cycles; clients moving to production; Gartner cited directly | Macro “unsettled”; guidance reflects prudent approach | Positive |
Cognizant (CTSH) | July 29, 2026 | Large deal bookings strong; financial services AI adoption accelerating; massive long-term AI market | Discretionary spend cautious; macro uncertainty elevated; 2/3 of Global 2000 not realizing AI gains | Mixed |
Accenture (ACN) | June 18, 2026 | AI structural tailwind; pilots to production; federal lapping; mid-market expansion; consulting bookings 4 consecutive quarters of growth | Middle East conflict disrupting discretionary spend; large deal push-outs; macro uncertainty widening guidance range | Mildly Positive |
Key Takeaway: The most important development since Q1 earnings is the $600M buyback authorization expansion (announced April 30 / disclosed May 5), which signals board confidence and provides a meaningful EPS tailwind beyond guidance. The June 4 Baird conference provided the most substantive post-earnings update, confirming Q2 bookings recovery and CV acceleration expectations.
Key Takeaway: No open-market buys or discretionary sales by executives since Q1 earnings. All transactions are routine — RSU grants to directors (May 28 annual grant cycle), RSU vesting/tax withholding for executives, and director compensation stock equivalent conversions. The absence of any discretionary selling by the CEO, CFO, or other senior executives is a mild positive signal, particularly given the stock’s sharp decline from ~$165 in late May to ~$125 in late June.
Open-Market Buys and Sells (Form 4, Codes P/S) — May 5 to August 3, 2026:
No open-market purchases (Code P) or open-market sales (Code S) were filed by any Gartner insider during this period. All transactions in the dataset are routine non-discretionary events.
Name | Title | Transaction Type | Shares | Date | Note |
Multiple Directors (10 directors) | Director | RSU Grant (Code A) | 1,489 RSUs each | May 28, 2026 | Annual director RSU grant cycle; routine compensation, not discretionary |
HALL EUGENE A | Chairman & CEO | Stock Dividend / Conversion (Code J — Acquisition) | 38 shares | May 29, 2026 | Routine dividend reinvestment / stock equivalent conversion; not a discretionary open-market purchase |
Safian Craig | EVP & CFO | Stock Dividend / Conversion (Code J — Acquisition) | 22 shares | May 29, 2026 | Routine dividend reinvestment / stock equivalent conversion; not a discretionary open-market purchase |
van Ham Dick | EVP, Global Technology Sales | Stock Dividend / Conversion (Code J — Acquisition) | 38 shares | May 29, 2026 | Routine dividend reinvestment / stock equivalent conversion; not a discretionary open-market purchase |
Kim Thomas Sang | EVP, Chief Legal Officer | RSU Vest + Tax Withholding (Codes M/F) | 1,130 vested; 355 withheld for taxes | May 4, 2026 | Routine RSU vesting; tax withholding is obligation-driven, not a discretionary sale |
Serra Eileen | Director | RSU Vest (Codes M — Acquisition) | 705 shares (June 1); 1,744 shares (June 8) | June 1 & June 8, 2026 | Routine RSU vesting; no associated sale filed |
Multiple Directors (10 directors) | Director | Stock Equivalent Conversion (Code A/J) | 100–215 CSEs each | July 1, 2026 | Quarterly director compensation conversion from cash to stock equivalents; routine, not discretionary |
Assessment: The insider transaction picture is clean — no discretionary selling despite the stock declining from ~$165 in late May to ~$125 in late June. The CEO (Gene Hall) and CFO (Craig Safian) have not filed any open-market sales. The May 29 Code J transactions for Hall, Safian, van Ham, and others are routine stock equivalent conversions (dividend reinvestment or deferred compensation plan conversions), not open-market purchases. The absence of insider selling during a significant stock decline is a mild positive signal, suggesting insiders do not view the current price as an opportunity to reduce exposure.
Source: SEC Form 4 Filings Database (Insider Transaction Data). Individual filing links available for each transaction.